Overview
Stephen Harris is a Radiation Oncologist in Lowell, Massachusetts. Dr. Harris is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Familial Prostate Cancer, Prostate Cancer, and Pancreatic Cancer. Dr. Harris is currently accepting new patients.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Hospital Dr, Lowell, MA 01852
1 Elliot Way, Manchester, NH 03103
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Massachusetts General Physicians Organization Inc
Florence Keane is a Radiation Oncologist in Boston, Massachusetts. Dr. Keane is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Pancreaticoduodenectomy. Dr. Keane is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Harris isDistinguished. Learn about Familial Prostate Cancer.
- Pleuropulmonary BlastomaDr. Harris isDistinguished. Learn about Pleuropulmonary Blastoma.
- Prostate CancerDr. Harris isDistinguished. Learn about Prostate Cancer.
- Advanced
- Familial Pancreatic CancerDr. Harris isAdvanced. Learn about Familial Pancreatic Cancer.
- Laryngeal CancerDr. Harris isAdvanced. Learn about Laryngeal Cancer.
- Lung CancerDr. Harris isAdvanced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Harris isAdvanced. Learn about Metastatic Brain Tumor.
- Pancreatic CancerDr. Harris isAdvanced. Learn about Pancreatic Cancer.
- Throat CancerDr. Harris isAdvanced. Learn about Throat Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Harris isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Harris isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Harris isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Harris isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Harris isExperienced. Learn about Angiosarcoma.

